IQVIA Holdings Inc.

IQV ·Healthcare, Diagnostics & Research, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011
Operating Activities
Net Income $1.28B $72.0M $387.0M $357.0M $226.6M $177.5M $241.8M
Depreciation & Amortization $1.01B $289.0M $128.0M $121.0M $107.5M $98.3M $92.0M
Depreciation $125.0M $79.0M $61.0M — — — —
Amortization $886.0M $210.0M $67.0M $58.0M $51.5M $46.4M $35.5M
Stock-Based Compensation $106.0M $106.0M $38.0M $30.0M $22.8M $25.9M $14.1M
Net Cash from Operating Activities $970.0M $860.0M $476.0M $433.0M $393.4M $335.7M $161.0M
Investing Activities
Capital Expenditures $369.0M $164.0M $78.0M $83.0M $88.3M $71.3M $75.7M
Business Acquisitions $854.0M $-1.89B $-32.0M $92.0M $145.0M $43.2M $227.1M
Net Cash from Investing Activities $-1.19B $1.73B — — — — —
Financing Activities
Dividends Paid — — — — — $567.9M $288.3M
Stock Repurchases $2.62B $1.10B $515.0M $415.0M $6.4M $13.4M $14.3M
Net Cash from Financing Activities $-72.0M $-2.28B — — — — —
Net Change in Cash $-239.0M $221.0M $110.0M $90.0M $210.4M $51.4M $-130.3M
Free Cash Flow $601.0M $696.0M $398.0M $350.0M $305.0M $264.4M $85.3M
← Newer Page 2 of 2 Older →